{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:56:11Z","timestamp":1793109371932,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85643-6","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T08:21:41Z","timestamp":1736410901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gossypol is a natural product with good antimalarial activity against Plasmodium falciparum clinical isolates"],"prefix":"10.1038","volume":"15","author":[{"given":"Jersley D.","family":"Chirawurah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Ansah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Blankson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Adikah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silas Nkansah","family":"Yeboah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Amenga-Etego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Awandare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaw","family":"Aniweh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"85643_CR1","unstructured":"WHO. in WHO global malaria programme: world malaria report 2010 204\u2013204. (2010)."},{"key":"85643_CR2","volume-title":"World malaria report 2014","author":"WHO","year":"2014","unstructured":"WHO. World Malaria Report 2014Vol. 23 (World Health Organization, 2014)."},{"key":"85643_CR3","volume-title":"World malaria report 2023","author":"WH Organization","year":"2023","unstructured":"Organization, W. H. World Malaria Report 2023 (World Health Organization, 2023)."},{"key":"85643_CR4","unstructured":"WHO. World malaria report 2019. Geneva: World Health Organization. Licence: CC BY-NC-SA 3.0 IGO. WHO (2019). (2019)."},{"key":"85643_CR5","unstructured":"WHO. World Malaria report 2015. Geneva: World Health Organization. WHO (2015). (2015)."},{"key":"85643_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp, A. M. et al. Artemisinin resistance in Plasmodium Falciparum malaria. N Engl. J. Med. 361, 455\u2013467. https:\/\/doi.org\/10.1056\/NEJMoa0808859 (2009).","journal-title":"N Engl. J. Med."},{"key":"85643_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong, M. et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect. Dis. 17, 491\u2013497. https:\/\/doi.org\/10.1016\/S1473-3099(17)30048-8 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"85643_CR8","volume-title":"World malaria report 2022","author":"WHO","year":"2022","unstructured":"WHO. World Malaria Report 2022 (World Health Organization, 2022)."},{"key":"85643_CR9","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","volume":"389","author":"S Mihreteab","year":"2023","unstructured":"Mihreteab, S. et al. Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea. N. Engl. J. Med. 389, 1191\u20131202 (2023).","journal-title":"N. Engl. J. Med."},{"key":"85643_CR10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana, A. et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium Falciparum kelch13 R561H mutant parasites in Rwanda. Nat. Med. 26, 1602\u20131608 (2020).","journal-title":"Nat. Med."},{"key":"85643_CR11","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","volume":"223","author":"V Asua","year":"2021","unstructured":"Asua, V. et al. Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda. J. Infect. Dis. 223, 985\u2013994 (2021).","journal-title":"J. Infect. Dis."},{"key":"85643_CR12","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","volume":"374","author":"A Olotu","year":"2016","unstructured":"Olotu, A. et al. Seven-year efficacy of RTS,S\/AS01 malaria vaccine among young African children. N Engl. J. Med. 374, 2519\u20132529. https:\/\/doi.org\/10.1056\/NEJMoa1515257 (2016).","journal-title":"N Engl. J. Med."},{"key":"85643_CR13","doi-asserted-by":"publisher","unstructured":"Coelho, C. H., Doritchamou, J. Y. A., Zaidi, I. & Duffy, P. E. Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium. NPJ Vaccines 2, 34 (2017). https:\/\/doi.org\/10.1038\/s41541-017-0035-3","DOI":"10.1038\/s41541-017-0035-3"},{"key":"85643_CR14","doi-asserted-by":"publisher","first-page":"e1005763","DOI":"10.1371\/journal.ppat.1005763","volume":"12","author":"WC Van Voorhis","year":"2016","unstructured":"Van Voorhis, W. C. et al. Open Source Drug Discovery with the Malaria Box compound Collection for Neglected diseases and Beyond. PLoS Pathog. 12, e1005763. https:\/\/doi.org\/10.1371\/journal.ppat.1005763 (2016).","journal-title":"PLoS Pathog"},{"key":"85643_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-018-2469-0","volume":"17","author":"RG Douglas","year":"2018","unstructured":"Douglas, R. G., Reinig, M., Neale, M. & Frischknecht, F. Screening for potential prophylactics targeting sporozoite motility through the skin. Malar. J. 17, 1\u201310 (2018).","journal-title":"Malar. J."},{"key":"85643_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/med.21643","volume":"40","author":"LS Feng","year":"2020","unstructured":"Feng, L. S. et al. Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug-resistant Plasmodium falciparum. Med. Res. Rev. 40, 931\u2013971. https:\/\/doi.org\/10.1002\/med.21643 (2020).","journal-title":"Med. Res. Rev."},{"key":"85643_CR17","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.bmcl.2018.05.060","volume":"28","author":"S Schiafino-Ortega","year":"2018","unstructured":"Schiafino-Ortega, S. et al. 1, 2-Diphenoxiethane salts as potent antiplasmodial agents. Bioorg. Med. Chem. Lett. 28, 2485\u20132489 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"85643_CR18","unstructured":"Heidrich, J., Hunsaker, L. & Vander Jagt, D. Gossypol, an antifertility agent, exhibits antimalarial activity in vitro. IRCS J. Med. Sci. (1983)."},{"key":"85643_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/pl00008549","volume":"86","author":"V Razakantoanina","year":"2000","unstructured":"Razakantoanina, V., Kim, N., Jaureguiberry, G. & P. P. & Antimalarial activity of new gossypol derivatives. Parasitol. Res. 86, 665\u2013668. https:\/\/doi.org\/10.1007\/pl00008549 (2000).","journal-title":"Parasitol. Res."},{"key":"85643_CR20","first-page":"305","volume":"76","author":"P Moh","year":"1992","unstructured":"Moh, P., Li, P., Darby, M., Brueggemeier, R. & Lin, Y. Characteristics of covalent gossypol binding to microsomal proteins. Res. Commun. Chem. Pathol. Pharmacol. 76, 305\u2013322 (1992).","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"85643_CR21","first-page":"417","volume":"4","author":"CG National","year":"1978","unstructured":"National, C. G. o. M. A. A. Gossypol-a new antifertility agent for males. Chin. Med. J. 4, 417\u2013428 (1978).","journal-title":"Chin. Med. J."},{"key":"85643_CR22","doi-asserted-by":"publisher","first-page":"1190471","DOI":"10.3389\/fddsv.2023.1190471","volume":"3","author":"JD Chirawurah","year":"2023","unstructured":"Chirawurah, J. D. et al. MMV006087 is a potent Malaria Box compound against Plasmodium Falciparum clinical parasites. Front. Drug Discovery. 3, 1190471 (2023).","journal-title":"Front. Drug Discovery"},{"key":"85643_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ijpddr.2017.10.005","volume":"7","author":"JD Chirawurah","year":"2017","unstructured":"Chirawurah, J. D. et al. Antimalarial activity of Malaria Box compounds against Plasmodium falciparum clinical isolates. Int. J. Parasitol. Drugs Drug Resist. 7, 399\u2013406. https:\/\/doi.org\/10.1016\/j.ijpddr.2017.10.005 (2017).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"85643_CR24","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1128\/AAC.03265-14","volume":"59","author":"M Chugh","year":"2015","unstructured":"Chugh, M. et al. Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains. Antimicrob. Agents Chemother. 59, 1110\u20131118 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"85643_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/1475-2875-10-268","volume":"10","author":"B Pradines","year":"2011","unstructured":"Pradines, B., Bertaux, L., Pomares, C., Delaunay, P. & Marty, P. Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia. Malar. J. 10, 268. https:\/\/doi.org\/10.1186\/1475-2875-10-268 (2011).","journal-title":"Malar. J."},{"key":"85643_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0166-6851(92)90081-t","volume":"51","author":"A Walker-Jonah","year":"1992","unstructured":"Walker-Jonah, A., Dolan, S. A., Gwadz, R. W., Panton, L. J. & Wellems, T. E. An RFLP map of the Plasmodium falciparum genome, recombination rates and favored linkage groups in a genetic cross. Mol. Biochem. Parasitol. 51, 313\u2013320. https:\/\/doi.org\/10.1016\/0166-6851(92)90081-t (1992).","journal-title":"Mol. Biochem. Parasitol."},{"key":"85643_CR27","doi-asserted-by":"publisher","first-page":"18883","DOI":"10.1073\/pnas.0911317106","volume":"106","author":"JM Sa","year":"2009","unstructured":"Sa, J. M. et al. Geographic patterns of Plasmodium Falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine. Proc. Natl. Acad. Sci. U S A. 106, 18883\u201318889. https:\/\/doi.org\/10.1073\/pnas.0911317106 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"85643_CR28","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nrd3301","volume":"9","author":"MT Tse","year":"2010","unstructured":"Tse, M. T. Antimalarial drugs: speeding to a new lead. Nat. Rev. Drug Discov. 9, 842. https:\/\/doi.org\/10.1038\/nrd3301 (2010).","journal-title":"Nat. Rev. Drug Discov"},{"key":"85643_CR29","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1021\/jm00159a043","volume":"29","author":"RE Royer","year":"1986","unstructured":"Royer, R. E., Deck, L. M., Campos, N. M. & Hunsaker, L. A. Vander Jagt, D. L. Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles. J. Med. Chem. 29, 1799\u20131801. https:\/\/doi.org\/10.1021\/jm00159a043 (1986).","journal-title":"J. Med. Chem."},{"key":"85643_CR30","first-page":"845","volume":"12","author":"D VanderJagt","year":"1984","unstructured":"VanderJagt, D., Baack, B., Campos, N., Hunsaker, L. & Royer, R. A derivative of gossypol retains antimalarial activity. IRCS Med. SCIENCE-BIOCHEMISTRY. 12, 845\u2013846 (1984).","journal-title":"IRCS Med. SCIENCE-BIOCHEMISTRY"},{"key":"85643_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrd4090","volume":"12","author":"J Arrowsmith","year":"2013","unstructured":"Arrowsmith, J., Miller, P. & Phase II and phase III attrition rates 2011\u20132012. Nat. Rev. Drug Discovery. 12, 569\u2013570 (2013).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"85643_CR32","doi-asserted-by":"crossref","unstructured":"Arrowsmith, J. & Phase, I. I. 2008\u20132010. Nat. Rev. Drug Discovery 10 (2011).","DOI":"10.1038\/nrd3439"},{"key":"85643_CR33","doi-asserted-by":"publisher","first-page":"20153038","DOI":"10.1098\/rspb.2015.3038","volume":"283","author":"M Bushman","year":"2016","unstructured":"Bushman, M. et al. Within-host competition and drug resistance in the human malaria parasite Plasmodium Falciparum. Proc. Biol. Sci. 283, 20153038. https:\/\/doi.org\/10.1098\/rspb.2015.3038 (2016).","journal-title":"Proc. Biol. Sci."},{"key":"85643_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1475-2875-3-33","volume":"3","author":"JC de Roode","year":"2004","unstructured":"de Roode, J. C., Culleton, R., Bell, A. S. & Read, A. F. Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections. Malar. J. 3, 33. https:\/\/doi.org\/10.1186\/1475-2875-3-33 (2004).","journal-title":"Malar. J."},{"key":"85643_CR35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/1475-2875-13-406","volume":"13","author":"KJ Gresty","year":"2014","unstructured":"Gresty, K. J. et al. Genetic mutations in pfcrt and pfmdr1 at the time of artemisinin combination therapy introduction in South Pacific islands of Vanuatu and Solomon Islands. Malar. J. 13, 406 (2014).","journal-title":"Malar. J."},{"key":"85643_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0014-4894(78)90136-4","volume":"46","author":"SG Langreth","year":"1978","unstructured":"Langreth, S. G., Nguyen-Dinh, P. & Trager, W. Plasmodium Falciparum: merozoite invasion in vitro in the presence of chloroquine. Exp. Parasitol. 46, 235\u2013238 (1978).","journal-title":"Exp. Parasitol."},{"key":"85643_CR37","first-page":"433","volume":"62","author":"C Lambros","year":"1984","unstructured":"Lambros, C. & Notsch, J. Plasmodium Falciparum: mefloquine resistance produced in vitro. Bull. World Health Organ. 62, 433 (1984).","journal-title":"Bull. World Health Organ."},{"key":"85643_CR38","first-page":"249","volume":"59","author":"C Brockelman","year":"1981","unstructured":"Brockelman, C., Monkolkeha, S. & Tanariya, P. Decrease in susceptibility of Plasmodium falciparum to mefloquine in continuous culture. Bull. World Health Organ. 59, 249 (1981).","journal-title":"Bull. World Health Organ."},{"key":"85643_CR39","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/0014-4894(88)90082-3","volume":"67","author":"AM Oduola","year":"1988","unstructured":"Oduola, A. M., Milhous, W., Weatherly, N., Bowdre, J. & Desjardins, R. Plasmodium Falciparum: induction of resistance to mefloquine in cloned strains by continuous drug exposure in vitro. Exp. Parasitol. 67, 354\u2013360 (1988).","journal-title":"Exp. Parasitol."},{"key":"85643_CR40","doi-asserted-by":"publisher","first-page":"20153038","DOI":"10.1098\/rspb.2015.3038","volume":"283","author":"M Bushman","year":"2016","unstructured":"Bushman, M. et al. Within-host competition and drug resistance in the human malaria parasite Plasmodium Falciparum. Proc. Royal Soc. B: Biol. Sci. 283, 20153038 (2016).","journal-title":"Proc. Royal Soc. B: Biol. Sci."},{"key":"85643_CR41","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1128\/AAC.01636-09","volume":"54","author":"B Witkowski","year":"2010","unstructured":"Witkowski, B. et al. Increased tolerance to artemisinin in Plasmodium Falciparum is mediated by a quiescence mechanism. Antimicrob. Agents Chemother. 54, 1872\u20131877 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"85643_CR42","doi-asserted-by":"crossref","unstructured":"Yu, X. et al. Ring-stage growth arrest: metabolic basis of artemisinin tolerance in Plasmodium Falciparum. Iscience 26 (2023).","DOI":"10.1016\/j.isci.2022.105725"},{"key":"85643_CR43","first-page":"1913","volume":"15","author":"S Mira-Mart\u00ednez","year":"2013","unstructured":"Mira-Mart\u00ednez, S. et al. Epigenetic switches in clag3 genes mediate blasticidin S resistance in malaria parasites. Cell. Microbiol. 15, 1913\u20131923 (2013).","journal-title":"Cell. Microbiol."},{"key":"85643_CR44","doi-asserted-by":"publisher","unstructured":"Mira-Mart\u00ednez, S. et al. Identification of antimalarial compounds that require CLAG3 for their uptake by Plasmodium falciparum-infected erythrocytes. Antimicrob. Agents Chemother. 63 https:\/\/doi.org\/10.1128\/aac.00052-19 (2019).","DOI":"10.1128\/aac.00052-19"},{"key":"85643_CR45","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41598-020-79539-w","volume":"11","author":"M Rawat","year":"2021","unstructured":"Rawat, M. et al. Histone acetyltransferase PfGCN5 regulates stress responsive and artemisinin resistance related genes in Plasmodium Falciparum. Sci. Rep. 11, 852 (2021).","journal-title":"Sci. Rep."},{"key":"85643_CR46","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager, W. & Jensen, J. B. Human malaria parasites in continuous culture. Science 193, 673\u2013675. https:\/\/doi.org\/10.1126\/science.781840 (1976).","journal-title":"Science"},{"key":"85643_CR47","doi-asserted-by":"crossref","unstructured":"Maier, A. G. & Rug, M. In vitro culturing Plasmodium Falciparum erythrocytic stages. Malaria: Methods Protocols, 3\u201315 (2013).","DOI":"10.1007\/978-1-62703-026-7_1"},{"key":"85643_CR48","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/infdis\/jiv207","volume":"212","author":"HE Mensah-Brown","year":"2015","unstructured":"Mensah-Brown, H. E. et al. Analysis of Erythrocyte Invasion mechanisms of Plasmodium Falciparum Clinical isolates across 3 Malaria-endemic areas in Ghana. J. Infect. Dis. 212, 1288\u20131297. https:\/\/doi.org\/10.1093\/infdis\/jiv207 (2015).","journal-title":"J. Infect. Dis."},{"key":"85643_CR49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12936-017-1745-8","volume":"16","author":"HE Mensah-Brown","year":"2017","unstructured":"Mensah-Brown, H. E. et al. Assessing the impact of differences in malaria transmission intensity on clinical and haematological indices in children with malaria. Malar. J. 16, 96. https:\/\/doi.org\/10.1186\/s12936-017-1745-8 (2017).","journal-title":"Malar. J."},{"key":"85643_CR50","unstructured":"Ljungstr\u00f6m, I., Moll, K., Perlmann, H., Scherf, A. & Wahlgren, M. Methods in malaria researchCiteseer,. (2008)."},{"key":"85643_CR51","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2307\/3280287","volume":"65","author":"C Lambros","year":"1979","unstructured":"Lambros, C. & Vanderberg, J. P. Synchronization of Plasmodium Falciparum erythrocytic stages in culture. J. Parasitol. 65, 418\u2013420 (1979).","journal-title":"J. Parasitol."},{"key":"85643_CR52","doi-asserted-by":"publisher","first-page":"11901","DOI":"10.1038\/ncomms11901","volume":"7","author":"VC Corey","year":"2016","unstructured":"Corey, V. C. et al. A broad analysis of resistance development in the malaria parasite. Nat. Commun. 7, 11901. https:\/\/doi.org\/10.1038\/ncomms11901 (2016).","journal-title":"Nat. Commun."},{"key":"85643_CR53","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/jac\/dkp449","volume":"65","author":"A Nzila","year":"2010","unstructured":"Nzila, A. & Mwai, L. In vitro selection of Plasmodium Falciparum drug-resistant parasite lines. J. Antimicrob. Chemother. 65, 390\u2013398. https:\/\/doi.org\/10.1093\/jac\/dkp449 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"85643_CR54","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein, M., Sriwilaijaroen, N., Kelly, J. X., Wilairat, P. & Riscoe, M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 48, 1803\u20131806. https:\/\/doi.org\/10.1128\/AAC.48.5.1803-1806.2004 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"85643_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-5-1","volume":"5","author":"ID Ferreira","year":"2006","unstructured":"Ferreira, I. D., Rosario, V. E. & Cravo, P. V. Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium Falciparum. Malar. J. 5, 1. https:\/\/doi.org\/10.1186\/1475-2875-5-1 (2006).","journal-title":"Malar. J."},{"key":"85643_CR56","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/s0035-9203(99)90120-7","volume":"93","author":"G Snounou","year":"1999","unstructured":"Snounou, G. et al. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans. R Soc. Trop. Med. Hyg. 93, 369\u2013374. https:\/\/doi.org\/10.1016\/s0035-9203(99)90120-7 (1999).","journal-title":"Trans. R Soc. Trop. Med. Hyg."},{"key":"85643_CR57","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1475-2875-10-276","volume":"10","author":"PI Mayengue","year":"2011","unstructured":"Mayengue, P. I., Ndounga, M., Malonga, F. V., Bitemo, M. & Ntoumi, F. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium Falciparum isolates from Brazzaville, Republic of Congo. Malar. J. 10, 276. https:\/\/doi.org\/10.1186\/1475-2875-10-276 (2011).","journal-title":"Malar. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85643-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85643-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85643-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T09:07:27Z","timestamp":1736413647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85643-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85643"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85643-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4934317\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1469"}}